Related Experiment Video
Updated: Jun 25, 2026
03:19
Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
L-methylfolate: a vitamin for your monoamines.
1Neuroscience Education Institute, 1930 Palomar Point Way, Ste. 101, Carlsbad, CA 92009, USA.
The Journal of Clinical Psychiatry
|February 6, 2009
Summary
L-methylfolate, a vitamin folate derivative, regulates the synthesis of key brain chemicals like serotonin and dopamine. This process is crucial for neurotransmitter production and overall brain health.
Area of Science:
- Neuroscience
- Biochemistry
- Nutritional Science
Background:
- Monoamine neurotransmitters, including serotonin, dopamine, and norepinephrine, are vital for numerous brain functions.
- The synthesis pathways of these neurotransmitters are complex and tightly regulated.
- Folate metabolism plays a critical role in cellular processes, including neurotransmitter synthesis.
Purpose of the Study:
- To elucidate the regulatory role of L-methylfolate in the synthesis of serotonin, dopamine, and norepinephrine.
- To understand the biochemical mechanisms by which folate derivatives influence monoamine neurotransmitter production.
Main Methods:
- Investigated the enzymatic activity related to monoamine synthesis in the presence of L-methylfolate.
- Utilized biochemical assays to quantify neurotransmitter levels.
- Analyzed the impact of folate derivatives on key regulatory enzymes.
Main Results:
- Demonstrated that L-methylfolate directly regulates the synthesis of serotonin, dopamine, and norepinephrine.
- Identified specific enzymatic steps influenced by L-methylfolate in the neurotransmitter pathways.
- Showcased the critical role of folate derivatives in maintaining adequate neurotransmitter levels.
Conclusions:
- L-methylfolate is a key regulator in the synthesis of essential monoamine neurotransmitters.
- This highlights the importance of adequate folate levels for neurological health and function.
- Further research into folate metabolism could reveal new therapeutic targets for neurological disorders.
Related Concept Videos
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:30Vitamins
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:17Phase II Reactions: Methylation Reactions
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...